S122N (p.Ser122Asn) variant of CDH2 (Cadherin-2)
S122N (p.Ser122Asn) in CDH2 (Cadherin-2) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The record also includes variant effect predictions and structural context.
S122N (p.Ser122Asn) variant details
- p.Ser122Asn
- NCI-TCGA TCGA novel
- Variant assessed as somatic; moderate impact.
- Missense
- MetaLR 0.12
- MetaSVM -1.00
- SIFT 0.42
- UniProt: Variant assessed as somatic; moderate impact.
- Structural context available